Dennis E. Marshall - 31 Dec 2021 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Director
Signature
/s/ John R. Browning, Attorney-in-fact
Issuer symbol
BLGO
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
4
Filing time
04 Jan 2022, 13:49:31 UTC
Previous filing
05 Oct 2021
Next filing
04 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLGO Option to Purchase Common Stock Award +63,750 +2.1% 3,108,183 31 Dec 2021 Common stock 63,750 $0.2100 Direct F1, F2
transaction BLGO Option to Purchase Common Stock Award +89,286 +2.9% 3,197,469 31 Dec 2021 Common stock 89,286 $0.2100 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was granted to Reporting Person to replace an option to purchase 225,000 shares that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
F2 Total reflects the expiration of options to purchase 235,000 shares that expired unexercised.
F3 This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2018 Equity Incentive Plan.